SCHEMBL8402875

SCHEMBL8402875

O=Cc1c(-c2ccccc2)nc2sc3ccccc3n12

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.49
LMNA P02545 3/20 0.49
RAB9A P51151 3/20 0.49
NPC1 O15118 2/20 0.49
SMN1; SMN2 Q16637 2/20 0.49
TP53 P04637 1/20 0.49
HPGD P15428 1/20 0.49
HSD17B10 Q99714 1/20 0.49
PDE1B Q01064 1/20 0.47
PDE3A Q14432 1/20 0.47
PDE11A Q9HCR9 1/20 0.47
RPS6KA3 P51812 3/20 0.43
HTT P42858 2/20 0.43
L3MBTL1 Q9Y468 2/20 0.43
POLB P06746 1/20 0.43
APEX1 P27695 1/20 0.43
TDP1 Q9NUW8 1/20 0.43
ACHE P22303 1/20 0.42
CHEK1 O14757 1/20 0.42
PDGFRA P16234 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11006013 0.89 LMNA (0.51) KDM4ELMNARAB9ANPC1SMN1; SMN2
SCHEMBL10463812 0.79 KDM4E (0.48) KDM4ELMNARAB9ANPC1SMN1; SMN2
SCHEMBL4104120 0.78 GSK3B (0.49) KDM4ELMNARAB9ANPC1SMN1; SMN2
SCHEMBL4104116 0.78 GSK3B (0.49) KDM4ELMNARAB9ANPC1SMN1; SMN2
SCHEMBL11004008 0.78 ADORA2A (0.50) KDM4ELMNARAB9ANPC1SMN1; SMN2
SCHEMBL20893062 0.78 RAB9A (0.49) KDM4ELMNARAB9ANPC1SMN1; SMN2
SCHEMBL20893208 0.78 RAB9A (0.49) KDM4ELMNARAB9ANPC1SMN1; SMN2
SCHEMBL11010858 0.77 KDM4E (0.49) KDM4ELMNARAB9ANPC1SMN1; SMN2
SCHEMBL10462335 0.76 CYP1A2 (0.52) KDM4ELMNARAB9ANPC1SMN1; SMN2
SCHEMBL7339029 0.74 KDM4E (0.46) KDM4ELMNARAB9ANPC1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5919799-A OVERCOMING RESISTANCE TO AN ANTI-NEOPLASTIC AGENT OR AN ENHANCER FOR THE EFFECT OF AN ANTI-NEOPLASTIC AGENT COMPRISING SAID ENHANCER FOR THE EFFECT OF AN ANTI-NEOPLASTIC AGENT NIKKEN CHEMICALS CO., LTD. (JP) 1999-07-06 US disclosed
EP-0816366-A1 IMIDAZOTHIAZOLE COMPOUNDS Nikken Chemicals Company, Limited (JP) 1998-01-07 EP disclosed